InPen App, CFN: MMT-8060 (iOS Users) and MMT-8061 (Android Users)

FDA Device Recall #Z-2496-2025 — Class II — June 16, 2025

Recall Summary

Recall Number Z-2496-2025
Classification Class II — Moderate risk
Date Initiated June 16, 2025
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Medtronic MiniMed, Inc.
Location Northridge, CA
Product Type Devices
Quantity 6816

Product Description

InPen App, CFN: MMT-8060 (iOS Users) and MMT-8061 (Android Users)

Reason for Recall

Medtronic MiniMed, Inc. is recalling InPen App for iOS and Android users due to software design errors that could lead to a missed short-acting insulin dose reminder and a recommendation to correct a high glucose value. It does not impact insulin delivery, long-acting insulin dose reminders, or CGM alerts, and users can still use the pen itself to calculate a dose, deliver insulin, record the dose date/time, and view CGM data. This issue was identified during internal testing before release in the US but after release to OUS customers, no complaints or MDRs related to this recall have been reported. Use of the affected device may result hyperglycemia by failing to alert the user and delay treatment of diabetes.

Distribution Pattern

International distribution to the countries of Argentina, Australia, Austria, Belgium, Bermuda, Chile, Czech Republic, Denmark, Egypt, Finland, France, Georgia, Germany, Greece, Hong Kong, Hungary, Iceland, India, Ireland, Israel, Italy, Luxembourg, Netherlands, New Zealand, Norway, Poland, Portugal, Romania, Saudi Arabia, Serbia, Singapore, South Africa, Spain, Sweden, Switzerland, United Arab Emirates, United Kingdom.

Lot / Code Information

UDI-DI: 0763000B000122075 CFN/Software Version: MMT-8060/7.0.0, 7.1.0, 7.2.0 and 7.5.0 MMT-8061/7.0.0, 7.0.1, 7.1.0, 7.1.1, 7.2.0 and 7.5.0

Other Recalls from Medtronic MiniMed, Inc.

Recall # Classification Product Date
Z-0958-2026 Class II InPen App, Model/CFN Number: MMT-8061 (Android ... Nov 13, 2025
Z-1238-2026 Class II MiniMed 780G Insulin Pump Catalog Numbers: MMT... Nov 2, 2025
Z-0594-2026 Class II CareLink Clinic, REF: MMT-7350 Oct 21, 2025
Z-0033-2026 Class II Medtronic, Simplera Sensor, REF: MMT-5100JD1 May 7, 2025
Z-1650-2025 Class II InPen smart insulin pen, REF: MMT-105NNBLNA, MM... Mar 4, 2025

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.